Satou Y, Utsunomiya A, Tanabe J, Nakagawa M, Nosaka K, Matsuoka M.

HTLV-1 modulates the frequency and phenotype of FoxP3+CD4+ T cells in virus-infected individuals.

Retrovirology. 2012 May 30;9:46. doi: 10.1186/1742-4690-9-46. PMID: 22647666; PMCID: PMC3403885.

https://pubmed.ncbi.nlm.nih.gov/22647666/

Masuda R, Oishi S, Tanahara N, Ohno H, Hirasawa A, Tsujimoto G, Kodama E, Matsuoka M, Fujii N.

Development and application of fluorescent SDF-1 derivatives.

Future Med Chem. 2012 May;4(7):837-44. doi: 10.4155/fmc.12.31. PMID: 22571609.

https://pubmed.ncbi.nlm.nih.gov/22571609/

Ghosh AK, Chapsal BD, Steffey M, Agniswamy J, Wang YF, Amano M, Weber IT, Mitsuya H.

Substituent effects on P2-cyclopentyltetrahydrofuranyl urethanes: design, synthesis, and X-ray studies of potent HIV-1 protease inhibitors.

Bioorg Med Chem Lett. 2012 Mar 15;22(6):2308-11. doi: 10.1016/j.bmcl.2012.01.061. Epub 2012 Feb 2. PMID: 22364812; PMCID: PMC3433276.

https://pubmed.ncbi.nlm.nih.gov/22364812/

Sohl CD, Singh K, Kasiviswanathan R, Copeland WC, Mitsuya H, Sarafianos SG, Anderson KS.

Mechanism of interaction of human mitochondrial DNA polymerase γ with the novel nucleoside reverse transcriptase inhibitor 4′-ethynyl-2-fluoro-2′-deoxyadenosine indicates a low potential for host toxicity.

Antimicrob Agents Chemother. 2012 Mar;56(3):1630-4. doi: 10.1128/AAC.05729-11. Epub 2011 Dec 12. PMID: 22155823; PMCID: PMC3294915.

https://pubmed.ncbi.nlm.nih.gov/22155823/

Kiyasu J, Aoki R, Tanaka PY, Pracchia LF, Calore EE, Perez NM, Kimura Y, Niino D, Sugita Y, Takayanagi R, Abe Y, Matsuoka M, Ohshima K.

FOXP3(+) regulatory and TIA-1(+) cytotoxic T lymphocytes in HIV-associated Hodgkin lymphoma.

Pathol Int. 2012 Feb;62(2):77-83. doi: 10.1111/j.1440-1827.2011.02754.x. PMID: 22243776.

https://pubmed.ncbi.nlm.nih.gov/22243776/

Ghosh AK, Anderson DD, Weber IT, Mitsuya H.

Enhancing protein backbone binding–a fruitful concept for combating drug-resistant HIV.

Angew Chem Int Ed Engl. 2012 Feb 20;51(8):1778-802. doi: 10.1002/anie.201102762. Epub 2012 Jan 31. PMID: 22290878.

https://pubmed.ncbi.nlm.nih.gov/22290878/

Kawano Y, Ueno S, Abe M, Kikukawa Y, Yuki H, Iyama K, Okuno Y, Mitsuya H, Hata H.

TRAIL produced from multiple myeloma cells is associated with osteolytic markers.

Oncol Rep. 2012 Jan;27(1):39-44. doi: 10.3892/or.2011.1491. Epub 2011 Oct 6. PMID: 21993926.

https://pubmed.ncbi.nlm.nih.gov/21993926/

Sugata K, Satou Y, Yasunaga J, Hara H, Ohshima K, Utsunomiya A, Mitsuyama M, Matsuoka M.

HTLV-1 bZIP factor impairs cell-mediated immunity by suppressing production of Th1 cytokines.

Blood. 2012 Jan 12;119(2):434-44. doi: 10.1182/blood-2011-05-357459. Epub 2011 Nov 28. PMID: 22123848; PMCID: PMC3257009.

https://pubmed.ncbi.nlm.nih.gov/22123848/

Ndongwe TP, Adedeji AO, Michailidis E, Ong YT, Hachiya A, Marchand B, Ryan EM, Rai DK, Kirby KA, Whatley AS, Burke DH, Johnson M, Ding S, Zheng YM, Liu SL, Kodama E, Delviks-Frankenberry KA, Pathak VK, Mitsuya H, Parniak MA, Singh K, Sarafianos SG.

Biochemical, inhibition and inhibitor resistance studies of xenotropic murine leukemia virus-related virus reverse transcriptase.

Nucleic Acids Res. 2012 Jan;40(1):345-59. doi: 10.1093/nar/gkr694. Epub 2011 Sep 8. PMID: 21908397; PMCID: PMC3245923.

https://pubmed.ncbi.nlm.nih.gov/21908397/

Douceron E, Kaidarova Z, Miyazato P, Matsuoka M, Murphy EL, Mahieux R.

HTLV-2 APH-2 expression is correlated with proviral load but APH-2 does not promote lymphocytosis.

J Infect Dis. 2012 Jan 1;205(1):82-6. doi: 10.1093/infdis/jir708. Epub 2011 Nov 7. PMID: 22065675; PMCID: PMC3242747.

https://pubmed.ncbi.nlm.nih.gov/22065675/

Tatetsu H, Tenen DG, Chai L.

The Interplay between Transcription Factor SALL4 and Histone Modifiers in Hematopoietic Stem and Progenitor Cells.

J Cell Immunol 3(1):26-30.2021.   doi: 10.33696/immunology.3.073.

https://pubmed.ncbi.nlm.nih.gov/33884376/